Cannara Biotech Inc. (TSXV:LOVE)
Canada · Delayed Price · Currency is CAD 1.690
-0.030 (-1.74%)
Oct 22, 2025, 3:59 PM EDT
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 154.52 million as of October 23, 2025. Its market cap has increased by 172.47% in one year.
Market Cap
154.52M
Enterprise Value
187.58M
Revenue
101.87M
Ranking
n/a
PE Ratio
9.95
Stock Price
1.69
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 154.52M, a decrease of -26.98%. That is a compound annual growth rate of -4.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 154.52M | 131.97% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | 59.03M | -33.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.22B |
| Green Thumb Industries | 2.63B |
| dentalcorp Holdings | 2.17B |
| Trulieve Cannabis | 2.15B |
| Sienna Senior Living | 1.82B |
| Cronos Group | 1.35B |
| Extendicare | 1.29B |
| WELL Health Technologies | 1.26B |